Analysed ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) News Sources
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
15-06-2026
yahoo.com
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
16-06-2026
yahoo.com
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
22-06-2026
yahoo.com
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
22-06-2026
yahoo.com
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
29-06-2026
yahoo.com
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
30-06-2026
yahoo.com
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member
02-07-2026
yahoo.com
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
06-07-2026
yahoo.com
What is the current price of ZEALAND PHARMA A/S (ZLDPF:OTCMKTS)?
The current price of ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) is $44.86.
ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) since the previous trading day is $-0.43.
ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) since the previous trading day is -0.9494%.
What is the most recent average sentiment score for ZEALAND PHARMA A/S (ZLDPF:OTCMKTS)?
The most recent average sentiment score for ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) is 53 out of 100.
What is the most recent average sentiment for ZEALAND PHARMA A/S (ZLDPF:OTCMKTS)?
The most recent sentiment for ZEALAND PHARMA A/S (ZLDPF:OTCMKTS) is .
SEC-8K** Filing Available For ZEALAND PHARMA A/S (ZLDPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.